Bringing new drugs to market in an increasingly competitive and regulated market is more challenging than ever for pharmaceutical companies. Deciding how and where to focus your go-to market efforts is key, but accessing the appropriate physician credentialing and real world data to inform your decisions can take months, introducing uncertainty and delaying the success of your launch.

Join industry experts from Bayer Pharmaceuticals, IQVIA and Snowflake on

• Challenges and opportunities facing Life Sciences organizations today
• Bayer Pharmaceuticals journey to bring their recent prescription medicine Verquvo to market
• Gain insight from IQVIA data faster through their partnership with Snowflake's Data Marketplace